Evidence map›Paper›PMID 40733178›Full record

ArticleMolecules (Basel, Switzerland)2025

Reinforcing Urea-Formaldehyde Resins with Low-Cost, Mechanically Derived Nanocellulose: A Sustainable Approach.

Eleni A Psochia, Emmanouil Karagiannidis, Eleftheria Athanasiadou, Konstantinos S Triantafyllidis

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eleni A PsochiaDepartment of Chemistry, Aristotle University of Thessaloniki, 54214 Thessaloniki, Greece.ORCID 0000-0001-6934-8476
Emmanouil KaragiannidisCHIMAR HELLAS S.A., 15 Km National Road, Thessaloniki-Polygyros, 57001 Thessaloniki, Greece.
Eleftheria AthanasiadouCHIMAR HELLAS S.A., 15 Km National Road, Thessaloniki-Polygyros, 57001 Thessaloniki, Greece.ORCID 0000-0003-3153-5326
Konstantinos S TriantafyllidisChemistry Department, King Fahd University of Petroleum and Minerals, Dhahran 31261, Saudi Arabia.ORCID 0000-0001-8658-8500

Funding

Operational Program Competitiveness, Entrepreneurship and Innovation (EPAnEK 2014-2020), European Regional Development Fund, European Union and Greek national funds Τ6ΥΒΠ-00341
6 · The paper itself

Abstract

In this work, we present the fabrication of low-cost, stable nanocellulose colloidal suspensions with an average particle size of approximately 160 nm, produced via a straightforward, solvent-free ultrasonication process that eliminates the need for corrosive chemicals or energy-intensive mechanical treatments. The resulting nanocellulose suspensions were utilized as reinforcing additives in urea-formaldehyde (UF) resins, which were subsequently applied in the production of particle boards. This approach addresses the increasing EU regulatory constraints regarding low formaldehyde-to-urea (F/U) molar ratios and the broader need for biobased, eco-friendly alternatives in the wood adhesive industry. Mechanical testing of the nanocellulose reinforced boards revealed notable improvements in the internal bond strength and modulus of rupture, along with a significant decrease in formaldehyde release compared to boards produced with conventional UF resins. These findings highlight the potential of ultrasonication-derived nanocellulose as an environmentally friendly, cost-effective additive to enhance the mechanical performance and reduce the environmental impact of UF-based wood composites.

Indexed as

aqueous colloidal suspensionsbiobased additivesformaldehyde emissionslow-costnanocelluloseparticle boardsultrasonicationurea-formaldehyde resins

Identifiers

PMID40733178
PMCPMC12300287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.